Dr. Reddy’s Laboratories Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

12.60$ -1.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Dr. Reddy’s Laboratories Ltd (RDY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 567,877 million INR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of INR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RDY
Line item	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Total Assets	194,762	207,650	219,821	225,604	225,427	3,070	3,631	292,827	321,854	387,518	492,989	567,877
Current Assets	119,838	119,688	100,375	109,645	114,501	1,723	2,028	181,856	204,253	248,049	250,112	295,997
Cash	39,654	39,955	18,136	2,638	2,228	27	203	14,852	5,779	7,107	14,654	15,064
Cash & Short-Term Investments	39,654	39,955	18,136	20,968	24,757	340	473	44,365	61,797	81,470	57,908	86,076
Receivables	48,595	48,604	45,737	50,200	46,630	816	844	80,270	83,203	95,338	109,792	99,215
Inventory	25,529	25,578	28,529	29,089	33,579	464	621	50,884	48,670	63,552	71,085	75,016
Property, Plant & Equipment	0.0	53,961	57,160	57,869	54,088	52,332	57,111	62,169	66,294	75,997	96,978	–
Goodwill	3,380	3,848	3,752	3,945	3,902	53	62	4,418	4,245	4,253	11,810	12,638
Intangible Assets	13,050	20,796	44,925	44,665	44,367	366	488	27,246	30,849	36,951	96,803	102,979
Total Liabilities	83,460	79,314	95,777	99,144	85,230	1,021	1,264	102,300	90,863	106,968	155,823	194,952
Current Liabilities	63,995	64,646	85,000	69,692	59,700	962	1,141	94,015	85,845	96,039	130,392	164,249
Short-Term Debt	28,906	22,828	43,736	25,625	16,381	275	328	28,099	12,194	14,030	38,902	63,848
Accounts Payable	10,660	12,300	13,417	9,208	10,296	142	174	15,971	17,857	21,547	20,053	32,750
Long-Term Debt	0.0	9,938	4,852	24,459	21,448	0.0	6,299	5,746	0.0	3,800	3,800	12,203
Shareholders' Equity	111,302	128,336	124,044	126,460	140,197	2,049	2,367	190,527	230,991	280,550	333,388	369,598
Retained Earnings	83,643	99,550	108,224	113,865	128,646	1,907	2,134	175,712	215,593	265,257	315,793	345,016
Shares Outstanding	855	855	835	831	831	830	832	832	832	834	834	833

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings